The event was organized to present the findings of the collaborative Spirulina research project, which has been carried out at both the IPS-ASTU and TMMRDD -AHRI labs. Dr. Ketema Tafess Tulu, Director of IPS, welcomed the participants and guests from AHRI, expressing his gratitude for their participation. He emphasized ASTU's commitment to advancing collaborative research with AHRI and other institutions, underscoring the university's role as a leader in science and technology.Dr. Ketema also highlighted IPS's ongoing projects, including the Spirulina research led by Dr. Yeshiemebet, and noted the importance of collaborations.

During the workshop, two key presentations were delivered. Dr. Yeshiemebet Major, Principal Investigator and focal person from IPS-ASTU, and Mr. Worku Gemechu, focal person from TMMRDD-AHRI, presented the findings. One presentation focused on the role of Spirulina as a nutraceutical, while the other examined its potential benefits in regulating blood glucose levels and treating diabetesin vivo study. Both studies highlighted Spirulina's significant nutritional and medicinal value, with the potential for transforming these findings into commercial products.

A fruitful discussion followed, focusing on strategies to commercialize the research findings and the need for a joint plan to guide future collaborative efforts between the two institutions.

Mrs. Frehiwot Teka, Director of TMMRDD, emphasized the importance of strengthening collaboration between the institutes. She called for diversifying the areas of cooperation, particularly through the use of expert knowledge and laboratory facilities available at both institutions.

The workshop concluded with a shared commitment to furthering the Spirulina research and exploring its potential applications in nutrition and healthcare.